Extended follow-up of a Phase II trial in relapsed, refractory multiple myeloma: Final time-to-event results from the SUMMIT trial

Paul G. Richardson*, Bart Barlogie, James Berenson, Seema Singhal, Sundar Jagannath, David H. Irwin, S. Vincent Rajkumar, Gordan Srkalovic, Melissa Alsina, Kenneth C. Anderson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

137 Scopus citations

Fingerprint

Dive into the research topics of 'Extended follow-up of a Phase II trial in relapsed, refractory multiple myeloma: Final time-to-event results from the SUMMIT trial'. Together they form a unique fingerprint.

Medicine & Life Sciences